Grovet is moving! Due to the relocating, we will be closed from May 29 to May 31 2024. No orders will be processed or shipped during this period. However, it is possible to place your order. More information about the relocating, you can find here. If you have any questions or concerns, please do not hestitate to contact us at info@grovet.com.

Hemosilate 125 mg/ml solution injectable 5 x 20 ml

SKU
HEMOSI01
Marque:
Ecuphar
Batch:
725141
Expiry date:
31-Jan-2027
Numéro d'enregistrement:
NL: REG NL 124505

Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.

Hemosilate is a hemostatic and angioprotective drug

Avertissement : le produit sur la photo peut différer du produit réel.

Hemosilate 125 mg/ml solution for injection

Hemosilate is a hemostatic and angioprotective drug that stimulates platelet adhesiveness shortening bleeding time and normalizing rapidly and lastly the altered vascular fragility and permeability. Its mechanism of action is attributed to the inhibition of prostacyclin (PGI2) synthesis.

Indications d'utilisation

For intravenous or intramuscular use. Use 5-12.5 mg etamsylate per kg body weight, depending on the seriousness of the bleeding.

Active substance: etamsylate 125 mg/ml

© 2024 Grovet B.V. All rights reserved.